© Reuters. Amgen Earnings, Revenue Beat in Q1
Investing.com – Amgen (NASDAQ:) reported on Wednesday first quarter that beat analysts’ forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.25 on revenue of $6.24B. Analysts polled by Investing.com anticipated EPS of $4.12 on revenue of $6.11B.
Amgen shares are up 10% from the beginning of the year, still down 3.83% from its 52 week high of $258.70 set on May 10, 2021. They are outperforming the which is down 20.32% from the start of the year.
Amgen shares gained 0.72% in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
Amgen’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment